PT  - JOURNAL ARTICLE
AU  - Diana P. Wehrendt
AU  - Mariana G. Massó
AU  - Adrián Gonzales Machuca
AU  - Claudia V. Vargas
AU  - Melina E. Barrios
AU  - Josefina Campos
AU  - Damián Costamagna
AU  - Luis Bruzzone
AU  - Daniel M. Cisterna
AU  - Néstor Gabriel Iglesias
AU  - Viviana A. Mbayed
AU  - Elsa Baumeister
AU  - Daniela Centrón
AU  - María Paula Quiroga
AU  - Leonardo Erijman
TI  - A rapid and simple protocol for concentration of SARS-CoV-2 from sewage
AID  - 10.1101/2021.05.27.21257934
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.05.27.21257934
4099  - http://medrxiv.org/content/early/2021/05/30/2021.05.27.21257934.short
4100  - http://medrxiv.org/content/early/2021/05/30/2021.05.27.21257934.full
AB  - The aim of this study was to set up a simple protocol to concentrate SARS-CoV-2 from sewage, which can be implemented in laboratories with minimal equipment resources. The method avoids the need for extensive purification steps and reduces the concentration of potential inhibitors of RT-qPCR contained in sewage. The concentration method consists of a single step, in which a small volume of sewage sample is incubated with polyaluminum chloride (PAC). Virus particles adsorbed to the precipitate are collected by low-speed centrifugation, after which the recovered pellet is resuspended with a saline buffer. The PAC concentration method produced an average shift of 4.4-units in Cq values compared to non-concentrated samples, indicating a 25-fold increase in detection sensitivity. The lower detection limit corresponded approximately to 100 copies per ml. Kappa index indicated substantial agreement between PAC and PEG precipitation protocols (k=0.688, CI 0.457-0.919). PAC concentrated samples can be processed immediately for RNA purification and qPCR or sent refrigerated to a diagnosis center, where SARS-CoV-2 detection should be performed in the same way as for clinical samples. This low cost protocol could be useful to aid in the monitoring of community circulation of SARS-CoV-2, especially in low- and middle-income countries, which do not have massive access to support from specialized labs for sewage surveillance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Programa de Articulacion y Fortalecimiento Federal de las Capacidades en Ciencia y Tecnologia COVID-19 (Proyecto BSAS-32; Ministerio de Ciencia, Tecnologia e Innovacion de la Nacion (MINCyT) to LE and by Grant IP No. 13 COVID 19 from ANPCyT to EB.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research did not require IRB oversightAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data will be available upon request